OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
OrthoPediatrics Corp. (NASDAQ: KIDS) has launched its Enabling Technologies division, aimed at expanding into digital health and advanced technology within pediatric orthopedics. Led by Kevin Unger, this division builds on the company's existing innovations like the 7D Flash™ Navigation System and partnership with 3D Side, S.A. for patient-specific cutting guides.
Two new platforms are set to launch:
- Playbook: A surgical workflow and outcome optimization platform
- Robotic-Assistance for Cochlear Implant Technology: Developed in partnership with iotaMotion, Inc.
CEO David Bailey emphasized that this division will help impact more children and provide long-term growth opportunities. The company is hosting an Investor Day on September 12, 2024, to discuss these developments further.
OrthoPediatrics Corp. (NASDAQ: KIDS) ha lanciato la sua divisione Tecnologie Abilitanti, con l'obiettivo di espandersi nella salute digitale e nella tecnologia avanzata nell'ortopedia pediatrica. Sotto la direzione di Kevin Unger, questa divisione si basa sulle innovazioni esistenti dell'azienda, come il sistema di navigazione 7D Flash™ e la partnership con 3D Side, S.A. per guide di taglio specifiche per il paziente.
Due nuove piattaforme sono pronte per essere lanciate:
- Playbook: Una piattaforma per l'ottimizzazione del flusso di lavoro chirurgico e dei risultati
- Assistenza Robotica per la Tecnologia degli Impianti Cocleari: Sviluppata in collaborazione con iotaMotion, Inc.
Il CEO David Bailey ha sottolineato che questa divisione aiuterà a impattare un numero maggiore di bambini e fornirà opportunità di crescita a lungo termine. L'azienda ospiterà un Investor Day il 12 settembre 2024, per approfondire ulteriormente questi sviluppi.
OrthoPediatrics Corp. (NASDAQ: KIDS) ha lanzado su división de Tecnologías Habilitadoras, con el objetivo de expandirse en la salud digital y la tecnología avanzada dentro de la ortopedia pediátrica. Liderada por Kevin Unger, esta división se basa en las innovaciones existentes de la empresa, como el sistema de navegación 7D Flash™ y la colaboración con 3D Side, S.A. para guías de corte específicas para el paciente.
Se lanzarán dos nuevas plataformas:
- Playbook: Una plataforma para la optimización del flujo de trabajo quirúrgico y los resultados
- Asistencia Robótica para la Tecnología de Implantes Cocleares: Desarrollada en colaboración con iotaMotion, Inc.
El CEO David Bailey enfatizó que esta división ayudará a impactar a más niños y proporcionará oportunidades de crecimiento a largo plazo. La empresa organizará un Investor Day el 12 de septiembre de 2024, para discutir más a fondo estos desarrollos.
OrthoPediatrics Corp. (NASDAQ: KIDS)는 지원 기술 부서를 출범시켜 소아 정형외과 분야의 디지털 건강 및 첨단 기술로의 확장을 목표로 하고 있습니다. Kevin Unger가 이끄는 이 부서는 7D Flash™ 네비게이션 시스템과 환자 맞춤형 커팅 가이드에 대한 3D Side, S.A.와의 파트너십과 같은 회사의 기존 혁신을 기반으로 하고 있습니다.
두 가지 새로운 플랫폼이 출시될 예정입니다:
- 플레이북: 수술 작업 흐름 및 결과 최적화 플랫폼
- 코클리아 이식 기술을 위한 로봇 지원: iotaMotion, Inc.와의 협력으로 개발되었습니다.
CEO David Bailey는 이 부서가 더 많은 아동에게 영향을 미치고 장기적인 성장 기회를 제공할 것이라고 강조했습니다. 회사는 2024년 9월 12일에 Investor Day를 개최하여 이러한 발전을 더 논의할 예정입니다.
OrthoPediatrics Corp. (NASDAQ: KIDS) a lancé sa division Technologies Facilitantes, visant à s'étendre dans la santé numérique et les technologies avancées au sein de l'orthopédie pédiatrique. Dirigée par Kevin Unger, cette division s'appuie sur les innovations existantes de l'entreprise, telles que le système de navigation 7D Flash™ et le partenariat avec 3D Side, S.A. pour des guides de découpe spécifiques au patient.
Deux nouvelles plateformes sont prêtes à être lancées :
- Playbook : Une plateforme pour l'optimisation des flux de travail chirurgical et des résultats
- Assistance Robotiques pour la Technologie des Implants Cochléaires : Développée en partenariat avec iotaMotion, Inc.
Le PDG David Bailey a souligné que cette division permettra d'impacter davantage d'enfants et d'offrir des opportunités de croissance à long terme. L'entreprise organisera un Investor Day le 12 septembre 2024 pour discuter plus en détail de ces développements.
OrthoPediatrics Corp. (NASDAQ: KIDS) hat seine Abteilung für Ermöglichende Technologien gegründet, die darauf abzielt, in den Bereichen digitale Gesundheit und fortschrittliche Technologien in der pädiatrischen Orthopädie zu expandieren. Unter der Leitung von Kevin Unger baut diese Abteilung auf den bestehenden Innovationen des Unternehmens, wie dem 7D Flash™ Navigationssystem und der Partnerschaft mit 3D Side, S.A. für patientenspezifische Schneideanleitungen, auf.
Zwei neue Plattformen sollen eingeführt werden:
- Playbook: Eine Plattform zur Optimierung von chirurgischen Arbeitsabläufen und Ergebnissen
- Robotische Unterstützung für Cochlea-Implantat-Technologie: Entwickelt in Zusammenarbeit mit iotaMotion, Inc.
CEO David Bailey betonte, dass diese Abteilung dazu beitragen wird, mehr Kindern zu helfen und langfristige Wachstumschancen zu bieten. Das Unternehmen veranstaltet am 12. September 2024 einen Investor Day, um diese Entwicklungen weiter zu besprechen.
- Launch of new Enabling Technologies division, expanding into digital health and advanced technology
- Introduction of Playbook platform for surgical workflow optimization
- Partnership with iotaMotion, Inc. for robotic-assisted cochlear implant technology
- Potential for long-term growth and market expansion beyond orthopedics
- None.
OrthoPediatrics' launch of the Enabling Technologies division marks a significant strategic shift for the company. This move into digital health and advanced technology demonstrates a commitment to innovation beyond traditional orthopedic devices. The division's focus on the Playbook platform and robotic-assisted cochlear implant technology shows potential for diversification and market expansion.
The Playbook platform could be a game-changer in surgical planning and execution, potentially improving outcomes and efficiency. This could lead to increased adoption and revenue streams from hospitals and surgical centers. The partnership with iotaMotion for cochlear implant technology is particularly intriguing, as it expands OrthoPediatrics' reach beyond orthopedics into otolaryngology, opening up new market opportunities.
However, investors should note that entering new technological domains carries risks, including potential R&D costs, regulatory hurdles and competition from established players in digital health and robotics. The success of this division will largely depend on the adoption rate of these new technologies and the company's ability to execute its strategy effectively.
The launch of the Enabling Technologies division represents a strategic pivot for OrthoPediatrics, potentially opening up new revenue streams and market opportunities. This move could diversify the company's product portfolio and reduce reliance on traditional orthopedic devices, which may lead to more stable and predictable revenue growth in the long term.
Investors should consider the potential impact on margins. While digital health solutions like Playbook could offer higher margins compared to hardware, the initial investment in R&D and marketing for these new technologies might pressure profitability in the short term. The partnership model, as seen with iotaMotion, could help mitigate some development costs but may also mean sharing potential revenues.
The expansion into new specialties like otolaryngology could increase the company's total addressable market. However, it's important to monitor the adoption rates of these new technologies and their contribution to revenue growth in the coming quarters to assess the success of this strategic shift.
OrthoPediatrics' new Enabling Technologies division represents a significant advancement in pediatric care. The Playbook platform has the potential to standardize and optimize surgical procedures, which is important in pediatric orthopedics where patient variability is high. This could lead to improved outcomes and reduced complications, benefiting both patients and healthcare providers.
The robotic-assisted cochlear implant technology is particularly exciting. Cochlear implants in children require extreme precision and a robotic system that allows for slow, controlled insertion could significantly reduce trauma and improve hearing outcomes. The fact that it's agnostic to implant manufacturers is a major advantage, allowing for broader adoption across different healthcare systems.
However, it's important to note that the adoption of new technologies in pediatric care can be slow due to heightened safety concerns. The success of these innovations will depend on robust clinical data demonstrating safety and efficacy in pediatric populations. OrthoPediatrics will need to invest heavily in clinical trials and education to drive adoption among pediatric specialists.
Additional details to be discussed during the Company’s Investor Day today, September 12, 2024
WARSAW, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the launch of its Enabling Technologies division. The Enabling Technologies division will leverage the company's core mission of addressing unmet pediatric needs in orthopedics and apply this focus to new areas within digital health and advanced technology. Led by industry veteran, Kevin Unger, this new division is set to differentiate OrthoPediatrics' core business, generate sustainable revenue growth, and access new markets and specialties beyond orthopedics.
OrthoPediatrics has already made significant strides in the field through its distribution of the 7D Flash™ Navigation System, and partnership with 3D Side, S.A. for patient-specific cutting guides. These innovations have laid a strong foundation for the Enabling Technologies division. The company is poised to build on this success with the upcoming launch of two groundbreaking technology platforms:
- Playbook: A cutting-edge surgical workflow and outcome optimization platform designed to enhance surgical planning, collaboration, and intraoperative workflow. Playbook aims to revolutionize how surgeries are planned and executed, resulting in improved outcomes and more efficient processes.
- Robotic-Assistance for Cochlear Implant Technology: OrthoPediatrics has partnered with iotaMotion, Inc. to bring a robotic-assisted insertion system designed to enhance the cochlear implant surgery. This technology offers a slow electrode array insertion that is agnostic to cochlear implant manufacturer, providing greater control and precision for pediatric patients.
"We are thrilled to introduce the new Enabling Technologies division, which will help us expand our ability to positively impact more children and provide significant long-term growth opportunities," said David Bailey, CEO of OrthoPediatrics. "This marks an exciting step forward in our commitment to innovation and helping kids. We believe these advancements will not only support our mission to improve pediatric care but also position us at the forefront of the pediatric digital health and enabling technologies sectors."
Investor Day Details: The Company will host an investor day at 10:30am E.T. on September 12, 2024, in New York, New York. The presentation will also be webcast live and a recording will be available on the Events & Presentations section on the investor relations website of www.orthopediatrics.com.ss
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets greater than 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
What new division has OrthoPediatrics (KIDS) launched?
What are the two new technology platforms OrthoPediatrics (KIDS) is launching?
When is OrthoPediatrics (KIDS) hosting its Investor Day to discuss these developments?
Who is leading OrthoPediatrics' (KIDS) new Enabling Technologies division?
